2019 Expert opinion on biological treatment use in inflammatory bowel disease management
dc.authorid | YILDIRIM, Süleyman/0000-0002-2607-6738 | |
dc.authorid | Dağlı, Ülkü/0000-0003-0664-0976; | |
dc.authorwosid | AKPINAR, HALE/Q-2507-2019 | |
dc.authorwosid | akyuz, filiz/AAS-8397-2020 | |
dc.authorwosid | ÇELİK, AYKUT FERHAT/AAB-4652-2021 | |
dc.authorwosid | YILDIRIM, Süleyman/HIK-2890-2022 | |
dc.authorwosid | Dağlı, Ülkü/S-4068-2018 | |
dc.authorwosid | Törüner, Murat/AAQ-1826-2020 | |
dc.contributor.author | Toruner, Murat | |
dc.contributor.author | Akpinar, Hale | |
dc.contributor.author | Akyuz, Filiz | |
dc.contributor.author | Dagli, Ulku | |
dc.contributor.author | Hamzaoglu, Hulya Over | |
dc.contributor.author | Tezel, Ahmet | |
dc.contributor.author | Unsal, Belkis | |
dc.date.accessioned | 2024-06-12T11:18:51Z | |
dc.date.available | 2024-06-12T11:18:51Z | |
dc.date.issued | 2019 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Takeda Turkey | en_US |
dc.description.sponsorship | The authors declared that this study was supported by Takeda Turkey with an unconditional educational grant. | en_US |
dc.identifier.doi | 10.5152/tjg.2019.061119 | |
dc.identifier.endpage | S946 | en_US |
dc.identifier.issn | 2148-5607 | |
dc.identifier.pmid | 32207688 | en_US |
dc.identifier.scopus | 2-s2.0-85079904412 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | S913 | en_US |
dc.identifier.uri | https://doi.org/10.5152/tjg.2019.061119 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/24986 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000504427700001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Aves | en_US |
dc.relation.ispartof | Turkish Journal Of Gastroenterology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Evidence-Based Consensus | en_US |
dc.subject | Severe Ulcerative-Colitis | en_US |
dc.subject | Tumor-Necrosis-Factor | en_US |
dc.subject | Anti-Tnf Therapy | en_US |
dc.subject | Active Crohns-Disease | en_US |
dc.subject | Maintenance Therapy | en_US |
dc.subject | Double-Blind | en_US |
dc.subject | 5-Aminosalicylic Acid | en_US |
dc.subject | Controlled-Trial | en_US |
dc.subject | Hepatitis-B | en_US |
dc.title | 2019 Expert opinion on biological treatment use in inflammatory bowel disease management | en_US |
dc.type | Article | en_US |